Physician profile
Daniel I Kim
NPI 1912009747
$1,148.51
in general payments reported to CMS, 2019-2025
10 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2023: $365 · 2024: $320 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $193.06 | 2024-2025 | Nanoknife |
| Abbott Laboratories | $169.16 | 2019 | |
| Teleflex LLC | $156.54 | 2024 | |
| Blue Earth Diagnostics | $146.36 | 2023 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Amgen INC. | $121.86 | 2023 | Evenity |
| Ars Pharmaceuticals Operations, INC. | $100.00 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $96.45 | 2023 | Farxiga |
| Myriad Genetic Laboratories, INC. | $21.57 | 2025 | Prolaris |
| Boston Scientific Corporation | $18.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.